Introduction N-(3',4'-dimethoxycinnamoyl) anthranilic acid (N-5') is a newly synthesized, anthranilic acid derivative. Given orally, N-5' potently inhibits the passive cutaneous anaphylaxis (PCA) mediated by homocytotropic antibodies (HTA). Koda, Nagai, Watanabe, Yanagihara & Sakamoto (1976) reported that N-5' inhibited HTA-induced PCA and mast cell degranulation in rats and guinea-pigs. They suggested that the anti-allergic properties of N-5' may be clinically useful in the treatment of allergyrelated diseases, especially asthma.
In view of the anti-inflammatory actions of anthranilic acid derivatives, N-5' has been compared with several established anti-inflammatory agents.
Methods
Passive cutaneous anaphylaxis in rats Preparation of antisera. Antiserum containing homocytotropic antibody (HTA, reagin antibody) was prepared in rats as described by Tada & Okumura (1971) . Male Wistar rats weighing 180 to 200 g were splenectomized and 5 days later immunized by injecting into all four footpads a total of 1 mg of 2,4-dinitrophenyl-coupled ascaris extract (DNP-As) mixed with 1010 Bordetella pertussis; 5 days later, 0.5 mg of DNP-As alone was injected subcutaneously into the back. Eight days after the first immunization, blood was collected by aortic puncture, under ether anaesthesia. The antiserum obtained by these procedures remained, when injected intradermally, in the skin for at least 1 week and was inactivated by heating at 56°C for 30 minutes. The titre of the antiserum was determined in rats by homologous PCA 48 h after injecting it intradermally. The dilution of antiserum producing a diameter of approximately 5 mm was usually 1: 500. Anti-bovine serum albumin (BSA) rabbit serum (anti-BSARS) was prepared by 4 weekly intramuscular injections of BSA (10 mg/kg) emulsified with an equal volume of complete Freund's adjuvant. Anti-BSARS injected intradermally The cells were sensitized by incubation, with occasional stirring, for 1 h at 370C in 4 ml of homocytotropic antiserum diluted with 0.9% w/v NaCl solution (saline) and containing 10 units of heparin. They were then washed twice with the buffer solution. Finally a suspension of about 6 x 10' mast cells/ml was prepared. Histamine release and its assay. After pre-warming to 370C for 5 min, 2.5 ml of the cell suspension was incubated for 20 min with 0.3 ml of test solution and 0.2 ml of 300 gg/ml DNP-As as antigen. The reaction mixture was then centrifuged at 500 g for 10 min at 40C.
The supernatant was assayed for released histamine and the precipitate for the residual cellular histamine according to the method of Shore, Burkhalter & Cohn (1959) .
Percentage release of histamine was calculated as The inhibition of histamine release by test drugs was calculated as (1-(D-S/C-S))x 100, where C, D, S =percentage release of histamine in controls, in the presence of test drugs, and in the absence of antigen (spontaneous), respectively. Drugs to be tested were dissolved in 1% aqueous solution of NaHCO3.
The following drugs were used: phenylbutazone, indomethacin, prednisolone, histamine dihydrochloride, 5-hydroxytryptamine creatinine sulphate, diphenhydramine hydrochloride, cyproheptadine hydrochloride, carrageenin, Evans blue (Merck), heparin (Novo), bovine serum albumin (Sigma) and Freund's complete adjuvant (Difco).
Results
Passive cutaneous anaphylaxis induced with homocytotropic antibodies To examine the effect of N-5' at doses of 100 and 200 mg/kg orally on PCA induced by HTA, N-5' was administered at 30, 60, 120 or 240 min before challenge with antigen (DNP-As). Inhibition was most potent at 30 or 60 min pretreatment with N-5', and negligible at 240 min pretreatment (Figure 1) . Thirty minutes pretreatment with drugs was therefore used when N-5' was compared with phenylbutazone, indomethacin and prednisolone. The amount of dye leaked as a result of PCA in controls was 10.4 + 0.90 jig/site and the area 105.1 + 2.90 mm2. N-5' produced a dosedependent, potent inhibition of the leakage, whereas phenylbutazone, indomethacin or prednisolone had little or no effect (Figure 2a ). The PCA was significantly inhibited by the combined pretreatment with 50 mg/kg of diphenhydramine and 10 mg/kg of cyproheptadine (not shown in Figure 2a ).
Passive cutaneous anaphylaxis induced with antibovine serum albumin rabbit serum The mean amount of dye leaked as a result of PCA induced by anti-BSARS in controls was 15.0 + 0.90 jg/site and the area 211.2 + 10.30 mm2 (Figure 2b) . Doses of N-5' which potently inhibited homologous PCA mediated by HTA, inhibited only slightly PCA induced by anti-BSARS. On the other hand, heterologous PCA was clearly inhibited by phenylbutazone, indomethacin and prednisolone in a dose-dependent manner. Diphenhydramine (50 mg/kg) and cyproheptadine (10 mg/kg), singly or combined, produced only a slight inhibition (not shown in Figure 2b ). by N-5' was most potent after 1 min and gradually decreased with longer preincubation times (not shown in Figure) . One minute pretreatment with drugs was therefore used ( Figure 5 ). Figure 5 shows the effect of 1, 10, 100 and 1000 gM N-5', phenylbutazone, indomethacin and prednisolone on the allergic histamine release from peritoneal cells. Mean total amount of histamine released as a result of antigen-antibody reaction from about 1.5 x 105 of rat peritoneal mast cells was 2.77 + 0.130 gg, corresponding to 38.1 + 1.56% of the total histamine content (7.3 jg/1.5 x 105 cells). The spontaneous release without antigen was 1 1.1 + 1.87%. The histamine release was significantly inhibited by 100 and 1000 gM N-5' but was hardly affected by the drug at a concentration of 1O gM or 1 gM. Phenylbutazone and indomethacin inhibited histamine release by 50% at a concentration of 1000 jM but had no effect at 100, 10 or 1 gM. Prednisolone had no effect at any concentration used. immunological properties (Mota, 1964; Bianaghi, Benacerraf, Block & Kourilsky, 1964) Goose & Blair (1969) .
N-5' and the anti-inflammatory agents inhibited only slightly the increased vascular permeability caused by histamine or 5-hydroxytryptamine. This suggested that the inhibitory action of N-5' on HTAinduced PCA was not due to antagonism to histamine and 5-hydroxytryptamine but to inhibition of the release of these mediators. The experiments with rat peritoneal cells suggested that N-5' acts mainly on histamine release. Phenylbutazone and indomethacin inhibited this release only in 1 mm concentrations. Prednisolone was inactive. According to Mota & Ishii (1960) , phenylbutazone (1540,ug/ml, about 5 mM) reduced anaphylactic histamine release only by 45%. The report that cortisone did not decrease the anaphylactic histamine release (Trethewie, 1958) agrees with our data. The inhibition by 1 mM phenylbutazone and indomethacin may depend on uncoupling of oxidative phosphorylation and/or membrane stabilization since Miller & Smith (1966) , Yamasaki & Saeki (1967) and Ignarro (1971) have shown that phenylbutazone and indomethacin inhibit the mast cell degranulation induced by compound 48/80, by depressing the processes generating ATP and their anti-inflammatory effects are associated with stabilization of the lysosomal membrane.
Rat paw oedema induced by carrageenin was effectively inhibited by the anti-inflammatory agents, but only slightly by N-5'. Yamasaki & Saeki (1967) , reported that phenylbutazone, indomethacin, flufenamic acid and mefenamic acid inhibited the inflammatory oedema produced in rats by rabbit antirat serum. This oedema was not inhibited by N-5' (Koda et al., 1976) . The pharmacological properties of the anthranilic acid derivative, N-5' appear to differ from those of anti-inflammatory agents. As proposed by Koda et al. (1976) , N-5' could be an anti-allergic clinical drug, effective by oral application. Other pharmacological properties of N-5' are now under investigation.
